Type 1 Diabetes Research Special Diabetes Program

What is the Special Statutory Funding Program for Type 1 Diabetes Research?

The Special Statutory Funding Program for Type 1 Diabetes Research, or Special Diabetes Program, is a special appropriation that the NIDDK administers on behalf of the Secretary of the Department of Health and Human Services, in collaboration with multiple NIH Institutes and Centers and the CDC, for research on the prevention and cure of type 1 diabetes.

The Special Diabetes Program has enabled the creation of unique, innovative, and collaborative research consortia and clinical trials networks focused on the prevention, treatment, and cure of type 1 diabetes. These consortia have made significant research progress and also generated numerous research resources for use by the broad scientific community. More information on research supported by the Program and the resulting scientific accomplishments are found in a Progress Report on the Special Type 1 Diabetes Program.

Legislative History of the Special Diabetes Program: Table 1 shows that special funding for type 1 diabetes research was initially provided by the Balanced Budget Act of 1997, Public Law (P.L.) 105-33 (now Section 330B of the Public Health Service Act). This funding was later extended and augmented by Section 931 of the 2001 Consolidated Appropriations Act (P.L. 106-554), the Public Health Service Act Amendment for Diabetes (P.L.107-360), the Medicare, Medicaid, and SCHIP Extension Act of 2007 (P.L. 110-173), the Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110-275), the Medicare and Medicaid Extenders Act of 2010 (P.L. 111-309), and the American Taxpayer Relief Act of 2012 (P.L. 112-240). The Table below summarizes the program's funding levels since its inception in 1998. This funding program supplements regularly appropriated funds that the NIH receives for diabetes research.



Table 1: Special Statutory Funds for Type 1 Diabetes Research-in Millions of Dollars
FY: 98 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 Total
P.L. 105-33 30 30 30 30 30 ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- 150
P.L. 106-554 ---- ---- ---- 70 70 100 ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- 240
P.L. 107-360 ---- ---- ---- ---- ---- ---- 150 150 150 150 150 ---- ---- ---- ---- ---- ---- 750
P.L. 110-173 ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- 150 ---- ---- ---- ---- ---- 150
P.L. 110-275 ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- 150 150 ---- ---- ---- 300
P.L. 111-309 ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- 150 150* ---- 300
P.L. 112-240 ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- 150* 150
TOTAL: 30 30 30 100 100 100 150 150 150 150 150 150 150 150 150 150 150 2,040*

* Due to the Budget Control Act of 2011, which sequestered funds for mandatory programs, actual funding levels were reduced to $142.35 million in FY13 and $139.2 million in FY14. Therefore, the actual total funding for FY98-FY14 is $2.02155 billion.

Last Updated: 03/10/2014

General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560 USA
For information about NIDDK programs: 301.496.3583